Which of the following is used in management of diabetes?
**Core Concept**
Bromocriptine is a dopamine receptor agonist that has been found to improve glycemic control in type 2 diabetes by enhancing insulin sensitivity and suppressing appetite. Its mechanism of action involves stimulation of dopamine receptors in the hypothalamus, leading to activation of the parasympathetic nervous system and suppression of the sympathetic nervous system, which contributes to improved insulin sensitivity.
**Why the Correct Answer is Right**
Bromocriptine's effect on insulin sensitivity is thought to be mediated through its activation of D2 receptors in the hypothalamus, which leads to increased expression of genes involved in glucose metabolism and insulin signaling. This results in improved glucose uptake in peripheral tissues and enhanced insulin secretion from pancreatic beta cells. Additionally, bromocriptine's appetite-suppressing effects contribute to weight loss, which is a critical factor in the management of type 2 diabetes.
**Why Each Wrong Option is Incorrect**
**Option B:** Octreotide is a somatostatin analogue used to manage symptoms of acromegaly and certain types of tumors, but it is not used in the management of diabetes. In fact, octreotide can worsen glucose control by inhibiting insulin secretion and increasing glucose levels.
**Option C:** Prednisolone is a corticosteroid used to treat various inflammatory and autoimmune conditions, but it can actually worsen glucose control in diabetes by promoting gluconeogenesis and reducing insulin sensitivity.
**Option D:** Pegvisomant is a growth hormone receptor antagonist used to manage acromegaly, but it is not used in the management of diabetes. In fact, growth hormone can have a diabetogenic effect by promoting gluconeogenesis and insulin resistance.
**Clinical Pearl / High-Yield Fact**
It's essential to note that bromocriptine's effect on insulin sensitivity is most pronounced in patients with type 2 diabetes who are overweight or obese, highlighting the importance of weight management in the treatment of this condition.
**β Correct Answer: A. Bromocriptine**